T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.62B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$1.61B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Lam Research
LRCX
|
+$1.17B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$1.4B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Tesla
TSLA
|
+$1.13B |
| 4 |
JPMorgan Chase
JPM
|
+$1.11B |
| 5 |
Morgan Stanley
MS
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 15.14% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Pediatrix Medical
MD
$2.14B
| $371M | 0.06% |
8,560,680
-1,004,843
| -11% | -$48.1M |
|
327
Douglas Emmett
DEI
$1.99B
| $370M | 0.06% |
9,205,493
+36,241
| +0.4% | +$1.37M |
|
328
CarGurus
CARG
$3.38B
| $369M | 0.06% |
10,629,035
-1,640,060
| -13% | -$55.2M |
|
|
WCG
329
DELISTED
Wellcare Health Plans, Inc.
WCG
| $366M | 0.06% |
1,488,101
-70,582
| -5% | -$15.4M |
|
330
Enovis
ENOV
$1.48B
| $366M | 0.06% |
6,940,571
-193,415
| -3% | -$10.5M |
|
331
Ulta Beauty
ULTA
$22.2B
| $366M | 0.06% |
1,567,809
+195,725
| +14% | +$47.3M |
|
332
Mercado Libre
MELI
$92.7B
| $365M | 0.06% |
1,219,767
-38,130
| -3% | -$12M |
|
|
SEM
333
DELISTED
Select Medical
SEM
| $365M | 0.06% |
37,275,898
+397,507
| +1% | +$3.9M |
|
334
NVIDIA
NVDA
$5.46T
| $364M | 0.06% |
61,516,720
+1,959,960
| +3% | +$11.9M |
|
335
Cintas
CTAS
$80.3B
| $363M | 0.06% |
7,854,156
+39,264
| +0.5% | +$1.77M |
|
336
Emerson Electric
EMR
$91.6B
| $362M | 0.06% |
5,236,041
-496,378
| -9% | -$34.9M |
|
337
SLM Corp
SLM
$5.22B
| $360M | 0.06% |
31,405,685
-2,580,899
| -8% | -$29.9M |
|
338
FirstService
FSV
$6.18B
| $358M | 0.05% |
4,711,832
+716,824
| +18% | +$51.4M |
|
339
Middleby
MIDD
$5.29B
| $353M | 0.05% |
3,376,277
-1,406,651
| -29% | -$159M |
|
340
Kroger
KR
$35.1B
| $352M | 0.05% |
12,360,509
+14,991
| +0.1% | +$377K |
|
|
CDK
341
DELISTED
CDK Global, Inc.
CDK
| $349M | 0.05% |
5,359,175
-178,636
| -3% | -$11.6M |
|
342
T-Mobile US
TMUS
$197B
| $347M | 0.05% |
5,802,928
-8,241,120
| -59% | -$488M |
|
|
EQC
343
DELISTED
Equity Commonwealth
EQC
| $346M | 0.05% |
10,986,170
-253,337
| -2% | -$7.83M |
|
|
DCT
344
DELISTED
DCT Industrial Trust Inc.
DCT
| $345M | 0.05% |
5,172,002
+3,852
| +0.1% | +$242K |
|
345
ConocoPhillips
COP
$150B
| $345M | 0.05% |
4,949,898
+2,823,341
| +133% | +$188M |
|
346
Synchrony
SYF
$26.1B
| $345M | 0.05% |
10,321,125
-12,707,421
| -55% | -$437M |
|
|
MINI
347
DELISTED
Mobile Mini Inc
MINI
| $344M | 0.05% |
7,335,664
-4,433
| -0.1% | -$200K |
|
348
ONE Gas
OGS
$5.09B
| $342M | 0.05% |
4,576,361
+15,462
| +0.3% | +$1.1M |
|
|
SIVB
349
DELISTED
SVB Financial Group
SIVB
| $339M | 0.05% |
1,174,740
-374,147
| -24% | -$110M |
|
350
Kohl's
KSS
$2.22B
| $339M | 0.05% |
4,650,617
-1,305,340
| -22% | -$87M |
|
Similar funds
T. Rowe Price Associates's Q2 2018 Portfolio in Review
As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
- T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
- T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
- T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.
Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.